Weight loss in patients with hematological neoplasias is associated with immune system stimulation
- 1 January 1993
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 71 (1) , 37-41
- https://doi.org/10.1007/bf00210961
Abstract
Weight loss is the main symptom of so-called tumor cachexia. The pathogenetic mechanisms underlying cachexia are poorly understood; however, it appears that enhanced formation of cytokines such as interferon-γ and tumor necrosis factor-α are involved. In 94 patients suffering from hematological neoplasias we compared body weight changes with serum neopterin, tryptophan, and kynurenine. Biochemical changes, the formation of neopterin, the degradation of tryptophan are closely related to interferon-γ activity. The majority of our patients had increased neopterin and decreased tryptophan concentrations. Weight loss was seen particularly in patients with higher neopterin and lower tryptophan values. An association between higher neopterin levels and greater weight loss was apparent at study entry and during the follow-up of patients. Our data support the concept that weight loss is closely linked to endogenous interferon-γ activity.Keywords
This publication has 19 references indexed in Scilit:
- Association between the activation of macrophages, changes of iron metabolism and the degree of anaemia in patients with malignant disordersEuropean Journal of Haematology, 1992
- Severe cachexia in mice inoculated with interferon‐γ‐producing tumor cellsInternational Journal of Cancer, 1991
- Correlation between neopterin, interferon‐gamma and haemoglobin in patients with haematological disordersEuropean Journal of Haematology, 1990
- HAEMOPOIETIC GROWTH FACTORS 1The Lancet, 1989
- Tumour Necrosis Factor-α and Lipopolysaccharide Enhance Interferon-Induced Tryptophan Degradation and Pteridine Synthesis in Human CellsBiological Chemistry Hoppe-Seyler, 1989
- Neopterin as a marker for activated cell-mediated immunity: Application in HIV infectionImmunology Today, 1988
- Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.The Journal of Experimental Medicine, 1988
- EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCERThe Lancet, 1987
- Human macrophages degrade tryptophan upon induction by interferon-gammaLife Sciences, 1987
- Prognostic effect of weight loss prior tochemotherapy in cancer patientsThe American Journal of Medicine, 1980